We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CVM market cap is 29.64M. The company's latest EPS is USD -0.3722 and P/E is -0.99.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.47M | -6.49M | -7.08M | -6.67M | -6.12M |
| Net Income | -7.63M | -6.71M | -7.24M | -7.52M | -6.11M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 559k | 0 | 0 | 0 | 0 |
| Operating Income | -28.98M | -36.19M | -36.06M | -31.48M | -26.35M |
| Net Income | -30.28M | -36.71M | -37.63M | -32.37M | -27.58M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.53M | 28.71M | 30.05M | 24.07M | 26.99M |
| Total Liabilities | 17.31M | 16.06M | 15.74M | 15.6M | 14.13M |
| Total Equity | 13.22M | 12.65M | 14.31M | 8.47M | 12.87M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.54M | 75.87M | 50.52M | 30.53M | 26.99M |
| Total Liabilities | 20.81M | 19.34M | 18.36M | 17.31M | 14.13M |
| Total Equity | 19.73M | 56.53M | 32.16M | 13.22M | 12.87M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.85M | -4.89M | -9.42M | -14M | -18.81M |
| Investing | -372k | -65k | -65k | -88k | -108k |
| Financing | 4.69M | 4.05M | 10.64M | 10.32M | 19.51M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.28M | -18.79M | -18.24M | -22.85M | -18.81M |
| Investing | -2.7M | -15.19M | 5.49M | -372k | -108k |
| Financing | 25.04M | 54.52M | -638k | 4.69M | 19.51M |
| Market Cap | 29.64M |
| Price to Earnings Ratio | -0.99 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 21.76 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 74.11M |
| Average Volume (1 week) | 1.1M |
| Average Volume (1 Month) | 1.09M |
| 52 Week Change | -85.96% |
| 52 Week High | 3.08 |
| 52 Week Low | 0.3567 |
| Spread (Intraday) | 0.02 (4.3%) |
| Company Name | Cel Sci Corporation New |
| Address |
7700 e arapahoe rd centennial, colorado 80112 1268 |
| Website | https://www.cel-sci.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
